Tazemetostat (hydrobromide)

CAS: 1467052-75-0

Category: Heterocyclic aromatic compound

Purity160 mg Tablets, ≥98% HPLC, Pharmaceutical Secondary Standard
Molecular FormulaC34H45BrN4O4
Molecular Weight653.65
AppearanceWhite to off-white solid
PackagingCustomizable
Testing IndicatorsAppearance — Visual inspection; Melting point — Capillary; Purity — HPLC; Identification — LC-MS, NMR; Moisture — Karl Fischer titration; Residual solvents — GC.
Storage NotesStore in a cool, dry, tightly closed container, protected from light and humidity.
Lead Time10 days
EZH2 inhibitor used as API for anticancer research and drug development.